Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 1, 1998, Pages 139-145

  Breeders, Martijn A W ^a   Tangelder, Geert Jan ^a,b   Slaaf, Dick W ^a   Reneman, Robert S ^a   Oude Egbrink, Mirjam G A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Intravital microscopy; Microcirculation; Nitric oxide; Thromboembolism pathophysiology; Vessel wall injury

Indexed keywords

ARGININE; DEXTRO ARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; VENULE;

EID: 0031964160     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.18.1.139     Document Type: Article

References (15)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol. 1993;344:251-264.
3. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;343:1199-1206.
4. Vanhoutte PM, Scott-Burden T. The endothelium in health and disease. Tex Heart Inst J. 1994;21:62-67.
5. Fukuto JM, Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Anna Rev Pharmacol Toxicol. 1995;35:165-194.
6. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298:249-258.
7. Pollock JS, Nakane M, Buttery LDK, Martinez A, Springall D, Polak JM, Förstermann U, Murad F. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol. 1993;265:C1379-C1387.
8. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol. 1990;101:325-328.
9. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinen H. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121-1131.
10. Busse R, Hecker M, Fleming I. Control of nitric oxide and prostacyclin synthesis in endothelial cells. Arzneimittelforschung. 1994;44:392-396.
11. Nishimura H, Rosenblum WI, Nelson GH, Boynton S. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo. Am J Physiol. 1991;261:H15-H21.
12. Rosenblum WI, Nishimura H, Ellis EF, Nelson GH. The endothelium-dependent effects of thimerosal on mouse pial arterioles in vivo: evidence for control of microvascular events by EDRF as well as prostaglandins. J Cereb Blood Flow Metab. 1992;12:703-706.
13. Rosenblum WI, Nishimura H, Nelson GH. L-NMMA in brain microcirculation of mice is inhibited by blockade of cyclooxygenase and by superoxide dismutase. Am J Physiol. 1992;262:H1343-H1349.
14. Ovize M, de Lorgeril M, Cathignol D, Delaye J, Renaud S. Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide. J Cardiovosc Pharmacol. 1990;16:641-645.
15. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992;86:1302-1309.